Investor's Business Daily on MSN20h
Novo Surges As Ozempic Drives Fourth-Quarter Beat. But Supply Shortages Expected.Novo Nordisk stock reversed a three-day downtrend Wednesday after the weight-loss drugs kingpin leaned on Ozempic for a fourth-quarter beat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback